These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3490239)

  • 1. Positron emission tomography in dementia of the Alzheimer type. A brief review with a case study.
    Berg G; Grady CL; Sundaram M; Haxby JV; Moore AM; White J; Heston L; Rapoport SI; Avioli LV
    Arch Intern Med; 1986 Oct; 146(10):2045-9. PubMed ID: 3490239
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered patterns of positron-emission tomography glucose metabolism in Alzheimer patients with microvascular white matter disease.
    De Leon MJ; George AE; Miller JD; Ferris SH; Klinger AJ; Franssen E; Kluger A; Sachs H; Gianutsos JG; La Regina ME
    Am J Physiol Imaging; 1988; 3(1):52-3. PubMed ID: 3260505
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron imaging in dementing illnesses.
    Friedland RP
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S56-60. PubMed ID: 2535422
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution of positron emission tomography to the diagnosis of dementia].
    Heiss WD; Herholz K; Pawlik G; Szelies B
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1362-7. PubMed ID: 3044727
    [No Abstract]   [Full Text] [Related]  

  • 5. Single photon emission tomographic brain images in dementia of the Alzheimer type.
    Hendrie HC; Wellman HN; Hall KS; Farlow MR; Brittain HM; Demyer MK
    Am J Psychiatry; 1987 Mar; 144(3):387-8. PubMed ID: 3493708
    [No Abstract]   [Full Text] [Related]  

  • 6. Subgroups in dementia of the Alzheimer type identified using positron emission tomography.
    Grady CL; Haxby JV; Schapiro MB; Gonzalez-Aviles A; Kumar A; Ball MJ; Heston L; Rapoport SI
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):373-84. PubMed ID: 2136389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in degenerative dementias.
    Salmon E; Franck G
    Acta Neurol Belg; 1989; 89(3-4):150-5. PubMed ID: 2516961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of positron emission tomography data for cerebral atrophy.
    Herscovitch P; Auchus AP; Gado M; Chi D; Raichle ME
    J Cereb Blood Flow Metab; 1986 Feb; 6(1):120-4. PubMed ID: 3484745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB.
    Weinberger DR; Mann U; Gibson RE; Coppola R; Jones DW; Braun AR; Berman KF; Sunderland T; Reba RC; Chase TN
    Adv Neurol; 1990; 51():147-50. PubMed ID: 2294653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent progress in the study of positron CT].
    Murakami K; Hatasawa J; Iida H; Kanno T
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):567-72. PubMed ID: 1619338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of brain function by positron CT].
    Ichimiya A; Yamada S; Suetsugu M; Nakao H
    Nihon Rinsho; 1987 Apr; 45(4):901-10. PubMed ID: 3302377
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of cerebral function with positron computed tomography.
    Phelps ME; Mazziotta JC; Huang SC
    J Cereb Blood Flow Metab; 1982; 2(2):113-62. PubMed ID: 6210701
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders.
    Bench CJ; Dolan RJ; Friston KJ; Frackowiak RS
    Br J Psychiatry Suppl; 1990; (9):82-95. PubMed ID: 2291823
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography.
    Nordberg A; Hartvig P; Lilja A; Viitanen M; Amberla K; Lundqvist H; Andersson J; Nybäck H; Ulin J; Anderson Y
    Acta Radiol Suppl; 1991; 376():165-6. PubMed ID: 1666767
    [No Abstract]   [Full Text] [Related]  

  • 16. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.
    Duara R; Barker WW; Chang J; Yoshii F; Loewenstein DA; Pascal S
    J Cereb Blood Flow Metab; 1992 Nov; 12(6):927-34. PubMed ID: 1400646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.
    Heiss WD; Hebold I; Klinkhammer P; Ziffling P; Szelies B; Pawlik G; Herholz K
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):613-7. PubMed ID: 3260597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PET imaging of dementia].
    Yokoi F; Ando K
    Nihon Rinsho; 1985 Jul; 43(7):1433-7. PubMed ID: 2932569
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional imaging in dementia: an overview.
    Jagust WJ
    J Clin Psychiatry; 1994 Nov; 55 Suppl():5-11. PubMed ID: 7989292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.